Anti-ACHA/ CHRNA1/ ACHRA monoclonal antibody

Anti-ACHA/ CHRNA1/ ACHRA antibody for FACS & in-vivo assay

Target products collectionGo to CHRNA1/CHRNA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T04689-Ab-1/ GM-Tg-hg-T04689-Ab-2Anti-Human CHRNA1 monoclonal antibodyHuman
GM-Tg-rg-T04689-Ab-1/ GM-Tg-rg-T04689-Ab-2Anti-Rat CHRNA1 monoclonal antibodyRat
GM-Tg-mg-T04689-Ab-1/ GM-Tg-mg-T04689-Ab-2Anti-Mouse CHRNA1 monoclonal antibodyMouse
GM-Tg-cynog-T04689-Ab-1/ GM-Tg-cynog-T04689-Ab-2Anti-Cynomolgus/ Rhesus macaque CHRNA1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T04689-Ab-1/ GM-Tg-felg-T04689-Ab-2Anti-Feline CHRNA1 monoclonal antibodyFeline
GM-Tg-cang-T04689-Ab-1/ GM-Tg-cang-T04689-Ab-2Anti-Canine CHRNA1 monoclonal antibodyCanine
GM-Tg-bovg-T04689-Ab-1/ GM-Tg-bovg-T04689-Ab-2Anti-Bovine CHRNA1 monoclonal antibodyBovine
GM-Tg-equg-T04689-Ab-1/ GM-Tg-equg-T04689-Ab-2Anti-Equine CHRNA1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T04689-Ab-1/ GM-Tg-hg-T04689-Ab-2; GM-Tg-rg-T04689-Ab-1/ GM-Tg-rg-T04689-Ab-2;
GM-Tg-mg-T04689-Ab-1/ GM-Tg-mg-T04689-Ab-2; GM-Tg-cynog-T04689-Ab-1/ GM-Tg-cynog-T04689-Ab-2;
GM-Tg-felg-T04689-Ab-1/ GM-Tg-felg-T04689-Ab-2; GM-Tg-cang-T04689-Ab-1/ GM-Tg-cang-T04689-Ab-2;
GM-Tg-bovg-T04689-Ab-1/ GM-Tg-bovg-T04689-Ab-2; GM-Tg-equg-T04689-Ab-1/ GM-Tg-equg-T04689-Ab-2
Products NameAnti-CHRNA1 monoclonal antibody
Formatmab
Target NameCHRNA1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CHRNA1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ACHA/ CHRNA1/ ACHRA VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003161human CHRNA1 Lentivirus plasmid
    ORF Viral VectorvGMLV000421human CHRNA1 Lentivirus particle
    ORF Viral VectorvGMLP003161human CHRNA1 Lentivirus particle
    ORF Viral VectorpGMLV000421human CHRNA1 Lentivirus plasmid


    Target information

    Target IDGM-T04689
    Target NameCHRNA1
    Gene ID1134,11435,79557,698578,403757,751106,338070,100065034
    Gene Symbol and SynonymsACHR,Achr-1,ACHRA,ACHRD,Acra,CHRNA,CHRNA1,CMS1A,CMS1B,CMS2A,FCCMS,SCCMS
    Uniprot AccessionP02708,P25108,P54250,P02709
    Uniprot Entry NameACHA_HUMAN,ACHA_RAT,ACHA_FELCA,ACHA_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000138435
    Target ClassificationIon Channel

    The target: CHRNA1, gene name: CHRNA1, also named as ACHRA, ACHRD, CHRNA, CMS1A, CMS1B, CMS2A, FCCMS, SCCMS. The muscle acetylcholine receptor consiststs of 5 subunits of 4 different types: 2 alpha subunits and 1 each of the beta, gamma, and delta subunits. This gene encodes an alpha subunit that plays a role in acetlycholine binding/channel gating. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Nov 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.